← Back to all signals
RESEARCH PAPER ANALYSIS

Effects of HPgV-1 Infections on Clinical Outcomes in Patients With Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Matched Case-Control Study.

AI interpretation is pending for this paper.

Open original publication →
PMID42126392
JournalClinical transplantation
Publication Date2026-05-01
Ingested2026-08-02 12:07 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Although the human pegivirus 1 (HPgV-1) infection is highly prevalent in immunocompromised populations, the effects of the infections on clinical outcomes in leukemia patients after stem cell transplantation (HSCT) are unclear. METHODS: A total of 16 acute lymphoblastic leukemia (ALL) patients with allogeneic HSCT (allo-HSCT) were included in this matched case-control study and 1-year survival outcomes were evaluated. RESULTS: One-year survival analysis showed that HPgV-1 infections could significantly decrease overall survival (OS), but non-significant differences in acute graft-versus-host disease (GVHD) grade III-IV, severe chronic GVHD, leukemia relapse, progression-free survival (PFS), and GVHD-free relapse-free survival (GRFS) were observed when compared with those without HPgV-1 infections. The infections also did not significantly impact the immune reconstitution. CONCLUSION: Our study suggests that HPgV-1 infections can decrease overall survivals in ALL patients at 1 year after allo-HSCT, which provides a foundation for larger, prospective, case-control studies to evaluate the overall effects of HPgV-1 infection on survival outcomes of leukemia patients with allo-HSCT.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Prevalence of Overweight, Obesity, and Abdominal Obesity and Their Associated Factors in Duhok City, Kurdistan Region, Iraq: A Population-Based Cross-Sectional Study. Journal of obesity 66.0 2 Childhood, adolescent, and early adult exposures and cancer risk in middle to late adulthood. Carcinogenesis 56.0 3 Exposure to per-and polyfluoroalkyl substances and early-onset cancers. Carcinogenesis 37.0 4 TPMT and NUDT15 Pharmacogenomic Profiles in Peruvian Patients With Pediatric Hematologic Malignancies. Frontiers in bioscience (Scholar edition) 66.3 5 H3F3B gene mutation in chondroblastomas: a multicenter study. Acta orthopaedica et traumatologica turcica 57.5 6 Chondroblastoma: the relationship between local invasiveness, recurrence, and histopathological features. Acta orthopaedica et traumatologica turcica 58.5 7 Neoadjuvant anti-HER2 antibody-drug conjugate SHR-A1811 in Hormone Receptor-positive, HER2-low Breast Cancer: A Phase 2 Clinical Trial (HELEN-015). Nature communications 86.12 8 Radiotherapy Reconstitutes the Collapsed miRNome of Progressive Neuroblastoma and Promotes a Favorable Tumor Evolutionary Shift. Frontiers in bioscience (Landmark edition) 65.64 9 [Surgical highlights of 2026 Rhinology Annual Conference: endoscopic resection of a juvenile nasopharyngeal angiofibroma with subdural intracranial extension]. Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery 28.5 10 A multicenter international case series highlighting the management of pediatric nephrogenic adenoma. Journal of pediatric urology 58.9 11 The BCG Vaccine: Pharmacological Biotechnology and Expanding Immunological Horizons. Frontiers in bioscience (Elite edition) 70.5 12 Synergistic antitumor effect of HMGB2 targeting combined with MDM2 inhibitor in diffuse intrinsic pontine glioma therapy. Frontiers in oncology 59.9 13 Pediatric ectodermal dysplasia with immunodeficiency caused by a hemizygous IKBKG frameshift variant: a case report and literature review. Frontiers in immunology 73.1 14 Allogeneic hematopoietic stem cell transplantation is associated with improved survival compared with chemotherapy in patients with acute myeloid leukemia harboring favorable-risk genetic features at initial diagnosis: a single-center retrospective study. Frontiers in immunology 79.76 15 Haematological toxicity associated with antineoplastic drugs: a pharmacovigilance analysis based on the FDA adverse event reporting system database. Frontiers in immunology 63.8 16 Development of a multidimensional disease burden assessment system for childhood neuroblastoma based on the social determinants of health theory. Frontiers in oncology 57.2 17 Case Report: Reconciling genomic ambiguity with clinical certainty in refractory panniculitis. Frontiers in immunology 50.72 18 Vitamin D signaling in thymic development and longevity. Frontiers in nutrition 42.1 19 Endobronchial fibroepithelial polyp presenting as persistent wheezing in a 9-year-old girl: a case report. Frontiers in pediatrics 50.3 20 Treatment patterns, intensive treatment, and hospitalization-related burden of juvenile generalized myasthenia gravis in Japan: a retrospective cohort study using a hospital-based claims database. Frontiers in neurology 77.64 21 Two-decade clinicopathological spectrum of gliomas at a tertiary center in LMIC: histological profile and the molecular diagnostic gap. Frontiers in oncology 64.9 22 Giant Mesenteric Cyst: A Case Series. International medical case reports journal 56.9 23 Application of Dual-Energy X-Ray Absorptiometry for Bone Mineral Density Screening in Pediatric, Adolescent, and Young Adult Cancer Survivors: A Multi-Institutional Study of 6 California Children's Hospitals. Journal of pediatric hematology/oncology 61.5 24 Childhood cancer and future cardiometabolic health. npj metabolic health and disease 56.9 25 Baseline Environmental Contamination Data and Model-based Screening of Children's Exposure-Risk Estimates from Metal(loid)-laden Vegetables and Soils. Toxicological sciences : an official journal of the Society of Toxicology 61.5 26 Beyond standard care: Fathers' perspectives on healthcare and related support services when caring for a child with a progressive life-limiting condition-A qualitative study. Palliative medicine 56.0 27 Bortezomib-based chemotherapy in Chinese pediatric patients with relapsed/refractory acute lymphoblastic leukemia: A single-center retrospective study. Pediatric investigation 79.78 28 Succinate dehydrogenase (SDHB, SDHC, SDHD) gene variants significantly modify clinical outcomes in paraganglioma-pheochromocytoma but have a limited impact on head and neck paraganglioma. Genetics in medicine : official journal of the American College of Medical Genetics 63.0 29 Cervicothoracic dumbbell ganglioneuroblastoma with spinal canal involvement and bone marrow metastasis: a case report and systematic review. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 76.3 30 Pediatric osteoporosis: a comprehensive imaging-based review of diagnosis, differential diagnosis, and etiology. Skeletal radiology 58.4 31 Frameless VarioGuide biopsy for pediatric brainstem lesions in the molecular era: diagnostic performance and workflow characteristics in a comparative single-center series. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 59.9 32 Isolated clival Langerhans cell histiocytosis in a pediatric patient: systematic review and illustrative case report. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 75.8
PATIENT-FRIENDLY SUMMARY

Effects of HPgV-1 Infections on Clinical Outcomes in Patients With Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Matched Case-Control Study.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic